Well, there is now good news for all pet parents: Merck Animal Health has received FDA approval for an important product advance in the category
of ectoparasiticides.
Not exact matches
The active substance
of BRAVECTO, fluralaner, an
ectoparasiticide belonging to the isoxazoline group, is systemically active against fleas and ticks.
The active substance
of BRAVECTO, fluralaner, a new
ectoparasiticide belonging to the isoxazoline group, is systemically active against fleas and ticks.